Skip to main content
Article thumbnail
Location of Repository

Prediction of Liver-Related Events Using Fibroscan in Chronic Hepatitis B Patients Showing Advanced Liver Fibrosis

By Seung Up Kim, Ji Hoon Lee, Do Young Kim, Sang Hoon Ahn, Kyu Sik Jung, Eun Hee Choi, Young Nyun Park, Kwang-Hyub Han, Chae Yoon Chon and Jun Yong Park
Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2010). A liver stiffness measurement-based, noninvasive prediction model for high-risk esophageal varices in B-viral liver cirrhosis.
  2. (2006). Accuracy of liver stiffness measurement for the diagnosis of cirrhosis in patients with chronic liver diseases.
  3. (2001). Acute variceal bleeding: general management.
  4. Aithal GP (2006) Guidelines on the management of ascites in cirrhosis.
  5. (1996). Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis.
  6. (1995). Chronic hepatitis. An update on terminology and reporting.
  7. (2006). Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.
  8. Dienstag JL (2007) Oral antivirals for chronic hepatitis B. Clin Liver Dis 11:851–868,
  9. (2012). Discordance between liver biopsy and FibroScanH in assessing liver fibrosis in chronic hepatitis B: Risk factors and influence of necroinflammation.
  10. (1998). Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients.
  11. (1986). Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.
  12. (2002). Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients.
  13. (1987). Follow-up study of 582 liver cirrhosis patients for 26 years in Japan.
  14. (1999). Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board,
  15. (1991). Hepatitis B: evolving epidemiology and implications for control.
  16. (1991). Hepatocellular carcinoma in Italian patients with cirrhosis.
  17. (1999). Hepatorenal syndrome.
  18. (1999). Histological changes in liver biopsies after one year of lamivudine treatment in patients with chronic hepatitis B infection.
  19. (2003). Histological outcome during long-term lamivudine therapy.
  20. (2004). Lamivudine for patients with chronic hepatitis B and advanced liver disease.
  21. (2001). Liver biopsy. N Engl J Med 344: 495–500. Fibroscan for Predicting Liver-Related Events PLoS
  22. (2006). Liver stiffness measurement selects patients with cirrhosis at risk of bearing large oesophageal varices.
  23. (2010). Lok A
  24. (1999). Long-term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection.
  25. (1992). Long-term survival following treatment of hepatocellular carcinoma in Singapore: evaluation of Wellferon in the prophylaxis of highrisk pre-cancerous conditions.
  26. (2005). Management of hepatocellular carcinoma.
  27. (2005). Management of patients with hepatitis B virus-induced cirrhosis.
  28. (2010). Mechanisms, diagnosis and management of hepatic encephalopathy.
  29. (1999). Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.
  30. (1989). Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective study.
  31. (2010). Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression.
  32. (2007). Non-invasive assessment of liver fibrosis by measuring the liver stiffness and biochemical markers in chronic hepatitis B patients.
  33. (2009). Non-invasive assessment of liver fibrosis by stiffness measurement in patients with chronic hepatitis B.
  34. (1999). Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
  35. (1995). Occurrence of hepatocellular carcinoma and decompensation in western
  36. (2011). Ontreatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients.
  37. (2011). Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).
  38. (2008). Risk assessment of hepatocellular carcinoma in chronic hepatitis C patients by transient elastography.
  39. (2006). Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
  40. (1994). Risk of hepatocellular carcinoma in patients with cirrhosis in Japan. Analysis of infectious hepatitis viruses.
  41. (1998). Spontaneous bacterial peritonitis. Clin Infect Dis 27:669–674; quiz 675–6.
  42. (1999). The long-term course of chronic hepatitis B.
  43. (2010). The utility of transient elastography in predicting complications of chronic liver disease.
  44. (2003). Transient elastography: a new noninvasive method for assessment of hepatic fibrosis.
  45. (2009). Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.